Quantitave and Qualitative Interferences of Pentoxifillyne on Hepatic Schistosoma mansoni Granulomas: Effects on Extracellular Matrix and Eosinophil Population

Memorias do Instituto Oswaldo Cruz

Volumn 96, Issue SUPPL., 2001, Pages 107-112

  Reis, Luis Felipe ^a   Ventura, Túlio Galvão ^a   Souza, Sônia Oliveira ^a   Arana Pino, Arturo ^b   Pelajo Machado, Marcelo ^b   Pereira, Mario José S ^b   Lenzi, Henrique Leonel ^b   Conceição, Maria José ^b   Takiya, Christina Maeda ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Collagen; Eosinophil; Mast cell; Pentoxifylline; Schistosoma mansoni

Indexed keywords

COLLAGEN; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITOR;

ANIMAL; ARTICLE; DRUG EFFECT; EOSINOPHIL; EXTRACELLULAR MATRIX; GRANULOMA; LIVER CIRRHOSIS; MALE; MAST CELL; MOUSE; PARASITIC LIVER DISEASE; PATHOLOGY; SCHISTOSOMA MANSONI;

ANIMALS; COLLAGEN; EOSINOPHILS; EXTRACELLULAR MATRIX; GRANULOMA; LIVER CIRRHOSIS; LIVER DISEASES, PARASITIC; MALE; MAST CELLS; MICE; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITORS; SCHISTOSOMIASIS MANSONI;

EID: 0035225975     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0074-02762001000900015     Document Type: Article

References (33)

1. Berman B, Duncan MR 1989. Pentoxifylline inhibits normal dermal fibroblasts in vitro proliferation, collagen, glycosaminoglycan and fibronectin production and increases collagenase activity. Br J Dermatol 123: 339-346.
2. Bienenstock J, Tomioka M, Stead R, Ernst P, Jordana M, Gauldie J, Dolovich J, Denburg J 1987. Mast cell involvment in various inflammatory process. Am Rev Res Dis 135: 55-58.
3. Bienvenu J, Doche C, Gutowski MC, Lenoble M, Lepape A, Perdrix JP 1995. Production of proinflammatory cytokines and cytokines involved in the TH1/TH2 balance is modulated by pentoxifylline. J Cardiovasc Pharmacol 25 (Suppl. 2): S80-84.
4. Bogomoletz W 1980. Avantages de la coloration par le rouge sirius de amyloide et des eosinophiles. Arch Anat Cytol Path 28: 252-253.
5. Borojevic R, Stocker S, Grimauld JA 1981. Hepatic eosinophil granulocytopoiesis in murine experimental schistosomiasis mansoni. Br J Exp Pathol 62: 480-489.
6. Boros DL, Lukacs NW 1992. The role of egg antigens, cytokine in granuloma formation in murine schistosomiasis mansoni. Mem Inst Oswaldo Cruz 87 (Suppl. IV): 75-79.
7. Brito JM, Borojevic R 1997. Liver granulomas in schistosomiasis: mast cell-dependent induction of SCF expression in hepatic stellate cells is mediated by TNF-α. J Leukoc Biol 62: 389-396.
8. Cheever AW, Xu Y, Macedonia JG, Cox T, Hieny S, Sher A 1992. The role cytokines in the pathogenesis of hepatic granulomatous disease in Schistosoma mansoni infected mice. Mem Inst Oswaldo Cruz 87 (Suppl. IV): 81-85.
9. Clutterbuck EJ, Hirst EM, Sanderson CJ 1989. Human interleukin-5(IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6 and GM-CSF. Blood 73: 1504-1512.
10. Curt MAJ, Samlaska P, Elizabeth CPT, Winfield A 1994. Pentoxifylline: is the pentoxifylline the drug of the decade? J Am Acad Dermatol 30: 603-621.
11. Davies WB, Fells GA, Sun XH, Gadek JE, Venet A, Crystal RG 1984. Eosinophil-mediated injury to lung parenchymal cell and interstitial matrix. J Clin Invest 74: 269-278.
12. Dolber PC, Spach MS 1993. Conventional and confocal microscopy of collagen fibers in the heart. J Histol Cytochitol 41: 465-469.
13. Duncan MR, Hasan A, Berman B 1995. Pentoxifylline, Pentifylline, and Interferons decrease type I and III percolagen m RNA levels in dermal fibroblasts: evidence for mediation by nuclear factor 1 down-regulation. J Invest Dermatol 104: 282-286.
14. Edwards MJ, Heniford BT, Klar EA, Doak KW, Miller FN 1992. Relationship between tumor necrosis factor-alpha and neutrophils in endotoxin-induced liver injury. J Clin Invent 90: 637-641.
15. El- Cheikh M, Borojevic R 1993. Extramedular proliferation of eosinophil granulocytes in chronic schistosomiasis mansoni is mediated by a factor secreted by inflamatory macrophages. Infect Immun 58: 816-821.
16. Friedman SL 1993. The celular basis of hepatic fibrosis. N Engl J Med 328: 1828-1835.
17. Hewett JA, Jean PA, Kunkel SL, Roth RA 1993. Pentoxifylline inhibits interleukin-2-induced toxicity in C57BL/6 mice but preserves antitunior efficacy. Am J Physiol 265: G1011-1015.
18. Hibbs MS, Mainard CL, Kang AH 1982. Type-specific collagen degradation by eosinophils. Biochem J 207: 621-624.
19. Isbrucker RA, Peterson TC 1998. Patelet-derived growth factor and pentoxifylline modulation of collagen synthesis in myofibroblasts. Toxicol Appl Pharm 149: 120-126.
20. Khalil RMD, Luz A, Mailhammer R, Moeller J, Mohamed AA, Omran S, Dörmer P, Hültner L 1996. Schistosoma mansoni infection in mice augments the capacity for interleukin 3 (IL-3) and IL-9 production and concurrently enlarges progenitor pools for mast cells and granulocytes-macrophages. Infect Immun 64: 4960-4966.
21. Lenzi HL, Kimmel E, Schechman H, Pelajo-Machado M, Vale BS, Panasco MS, Lenzi JA 1998. Collagen arragement in hepatic granuloma in mice infected with Schistosoma mansoni: dependence on fiber radiation centers. Braz J Med Bio Res 32: 639-643.
22. Lenzi HL, Lenzi JÁ, Rosman FC, Pelajo-Machado M, Mota EM, Panasco MS, Oliveira DN 1997. Extramedullary hematopolesis in murine schistosomiasis mansoni. Mem Inst Oswaldo Cruz 90: 169-177.
23. Lenzi HL, Sobral ACL, Lenzi JA 1987. In vivo kinects of eosinophils and mast cells in experimental murine schistosomiasis. Mem Inst Oswaldo Cruz 82 (Suppl. IV): 67-76.
24. Peterson TC 1993. Pentoxifylline prevents fibrosis in an animal model and inhibits platelet-derived growth factor-driven proliferation of fibroblasts. Hepatology 17: 486-498.
25. Pinzani M, Marra F, Caliguri A, De Franco R, Gentilini A, Failli P, Gentilini P 1996. Inhibition by pentoxifylline of extracellular signal-regulated kinase activation by platelet-derived growth factor in hepatic stellate cells. Br J Pharmacol 119: 1117-1124.
26. Preaux AM, Mallat A, Rosenbaum J, Zafrani ES, Mavier P 1997. Pentoxifylline inhibits growth and collagen syntesis of cultured human hepatic myofibroblast-like cells. Hepatology 26: 315-322.
27. Romanelli RG, Caliguri A, Carloni V, De Franco R, Montalto P, Ceni E, Casini A, Gentilini P, Pinzani M 1997. Effect of pentoxifylline on the degradation of procollagen type I produced by human hepatic stellate cells in response to trtansforming growth factor-Beta 1. Br J Pharmacol 122: 1047-1054.
28. Rosenthal LA, Taub DD, Moors MA, Blank KJ 1992. Methylxanthine-induced inhibition of the antigen-and superantigen-specific activation of T and B lymphocytes. Immunopharmacology 24: 203-217.
29. Rott O, Cash E, Fleischer B 1993. Phosphodiesterase inhibitor pentoxifylline, a seletive supressor of T helper type 1 - but not type 2 - associeted lymphokine production, prevents induction of experimental autoimmune encephalomyelitis in lewis rats. Eur J Immunol 23: 1745-1751.
30. Schmidt-Choudhury A, Furuta GT, Lavigne JA, Galli SJ, Wershil BK 1996. The regulation of tumor necrosis factor production in murine mast cells: pentoxifylline or dexamethasone inhibits IgE-dependent production of TNF-α by distinct mechanisms. Cell Immunol 171: 140-146.
31. Schuppan D, Herbst H, Milani S 1993. Matrix, matrix synthesis, and molecular network in hepatic fibrosis. In MA Zern, LM Reid (eds), Extracellular Matrix: Chemistry, Biology, and Pathobiology with Emphasis on the Liver, Marcel Dekker, Inc., New York, p. 201-254.
32. Sher A, Coffman R, Hieny S, Scott P, Cheever AW 1990. Interleukin 5 is required for the blood and tissue eosiniphilia but not granuloma formation induced by infection with Schistosoma mansoni. Proc Natl Acad Sci USA 87: 61-65.
33. Windmeier C, Gressner AM 1996. Effect of pentoxifylline on the fibrogenic functions of cultured rat liver fat-storing cells and myofibroblast. Biochem Pharm 51: 577-584.